1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1naresh
Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1:

FROC parameters of gliomas and normal contralateral thalamus of patients with low-grade and high-grade gliomas

D (μm2/ms)βμ (μm)
Gliomas
    LG1.54 ± 0.350.85 ± 0.058.43 ± 0.63
    HG1.19 ± 0.360.77 ± 0.068.01 ± 0.59
    P valuea<.001<.001.011
NCTH
    LG0.76 ± 0.060.78 ± 0.037.33 ± 0.38
    HG0.76 ± 0.040.78 ± 0.037.34 ± 0.33
    P valuea.876.706.890
  • Note:—NCTH indicates normal contralateral thalamus; LG, low-grade; HG, high-grade.

  • a Mann-Whitney U test.